Market Overview:
The global gene transplant market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The growth of the market can be attributed to the increasing prevalence of cancer and other diseases, rising demand for personalized medicine, and technological advancements in gene therapy. The global gene transplant market is segmented by type into ex vivo and in vivo gene transplants. The ex vivo segment is expected to grow at a higher CAGR than the in vivo segment during the forecast period. This can be attributed to the advantages offered by ex vivo gene therapy such as reduced risk of infection, lower toxicity, and ability to target specific cells. The global gene transplant market is also segmented by application into cancer diseases, hematological disease, hereditary disease, and others (cardiovascular diseases, metabolic disorders). Cancer diseases are estimated to account for the largest share of the global Gene transplant market in 2018 owing to increasing incidence rates of various types of cancers across the globe.
Product Definition:
Gene transplant is the process of transferring genes from one organism to another. It is used to treat genetic disorders, cancer, and other diseases. Gene transplant can also be used to improve the characteristics of plants and animals.
Ex Vivo:
Ex vivo is Latin for “from live” and it refers to the process of studying a biological system outside of living tissue. In most cases, ex vivo techniques are used in research on human diseases. Ex vivo techniques help obtain information about disease pathogenesis, drug discovery & development as well as provides an understanding about normal functioning of a particular organ or tissue.
The global ex vivo gene therapy market size was valued at USD 1,Billion in 2018.
In Vivo:
In vivo is Latin for living and refers to a procedure where the research is conducted on animals, which are then put back as the study subject. In vivo studies are used to understand how a new drug or treatment will affect living organisms.
It's major use in gene therapy market includes testing of transgenes in animal models before attempting to introduce them into human cells/tissue.
Application Insights:
The others segment held the largest share of gene therapy market in 2017. This segment includes genetic diseases, neurological disease and other disorders. The growing number of patients suffering from rare diseases is expected to contribute to the growth of this segment during the forecast period.
On the other hand, cancer dominated this application segment due to increasing prevalence and incidence rate of different types of cancer across globe. According to WHO, around 1 in 6 people are estimated to be diagnosed with cancer during their lifetime while another 1 in 5 deaths are caused by cancer globally every year since 2013 (before that it was stated as around 1 in 4 death).
Regional Analysis:
North America dominated the global gene transplant market in 2017. This can be attributed to the presence of sophisticated healthcare infrastructure, high adoption of advanced technologies, and availability of effective treatment methods for various diseases. Moreover, increasing number of clinical trials that use animal-cell based therapies is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare facilities in emerging countries such as China and India. Furthermore, growing investment by pharmaceutical companies for developing novel drugs will support regional growth during the study period 2016–2030 (previously 2020 – 2027). For instance, Sun Pharma & WOCKHARDT are collaborating with a focus on new drug development program which includes identification of target molecules using cell culture models (in vitro) followed by pre-clinical studies (in vivo).
Growth Factors:
- Increasing prevalence of chronic diseases such as cancer, diabetes, and heart diseases is expected to drive the demand for gene transplant in the coming years.
- Rising awareness about the benefits of gene therapy is anticipated to propel the growth of this market in the near future.
- Technological advancements in gene therapy are projected to create new opportunities for players operating in this market over the next few years.
- Growing investments by key players for research and development activities is likely to boost growth of this market during forecast period.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gene Transplant Market Research Report
By Type
Ex Vivo, In Vivo
By Application
Cancer Diseases, Hematological Disease, Hereditary Disease, Others
By Companies
Gilead (Kite Pharma), Amgen (BioVex), Novartis, Roche (Spark Therapeutics)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Gene Transplant Market Report Segments:
The global Gene Transplant market is segmented on the basis of:
Types
Ex Vivo, In Vivo
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Diseases, Hematological Disease, Hereditary Disease, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Gilead (Kite Pharma)
- Amgen (BioVex)
- Novartis
- Roche (Spark Therapeutics)
Highlights of The Gene Transplant Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ex Vivo
- In Vivo
- By Application:
- Cancer Diseases
- Hematological Disease
- Hereditary Disease
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gene Transplant Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gene transplant is a medical procedure in which cells from one person are transferred into the body of another person to treat a disease or condition.
Some of the major players in the gene transplant market are Gilead (Kite Pharma), Amgen (BioVex), Novartis, Roche (Spark Therapeutics).
The gene transplant market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Gene Transplant Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Gene Transplant Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Gene Transplant Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Gene Transplant Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Gene Transplant Market Size & Forecast, 2018-2028
4.5.1 Gene Transplant Market Size and Y-o-Y Growth
4.5.2 Gene Transplant Market Absolute $ Opportunity
Chapter 5 Global Gene Transplant Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Gene Transplant Market Size Forecast by Type
5.2.1 Ex Vivo
5.2.2 In Vivo
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Gene Transplant Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Gene Transplant Market Size Forecast by Applications
6.2.1 Cancer Diseases
6.2.2 Hematological Disease
6.2.3 Hereditary Disease
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Gene Transplant Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Gene Transplant Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Gene Transplant Analysis and Forecast
9.1 Introduction
9.2 North America Gene Transplant Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Gene Transplant Market Size Forecast by Type
9.6.1 Ex Vivo
9.6.2 In Vivo
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Gene Transplant Market Size Forecast by Applications
9.10.1 Cancer Diseases
9.10.2 Hematological Disease
9.10.3 Hereditary Disease
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Gene Transplant Analysis and Forecast
10.1 Introduction
10.2 Europe Gene Transplant Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Gene Transplant Market Size Forecast by Type
10.6.1 Ex Vivo
10.6.2 In Vivo
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Gene Transplant Market Size Forecast by Applications
10.10.1 Cancer Diseases
10.10.2 Hematological Disease
10.10.3 Hereditary Disease
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Gene Transplant Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Gene Transplant Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Gene Transplant Market Size Forecast by Type
11.6.1 Ex Vivo
11.6.2 In Vivo
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Gene Transplant Market Size Forecast by Applications
11.10.1 Cancer Diseases
11.10.2 Hematological Disease
11.10.3 Hereditary Disease
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Gene Transplant Analysis and Forecast
12.1 Introduction
12.2 Latin America Gene Transplant Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Gene Transplant Market Size Forecast by Type
12.6.1 Ex Vivo
12.6.2 In Vivo
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Gene Transplant Market Size Forecast by Applications
12.10.1 Cancer Diseases
12.10.2 Hematological Disease
12.10.3 Hereditary Disease
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Gene Transplant Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Gene Transplant Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Gene Transplant Market Size Forecast by Type
13.6.1 Ex Vivo
13.6.2 In Vivo
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Gene Transplant Market Size Forecast by Applications
13.10.1 Cancer Diseases
13.10.2 Hematological Disease
13.10.3 Hereditary Disease
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Gene Transplant Market: Competitive Dashboard
14.2 Global Gene Transplant Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Gilead (Kite Pharma)
14.3.2 Amgen (BioVex)
14.3.3 Novartis
14.3.4 Roche (Spark Therapeutics)
